Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients
The use of intravenous bisphosphonates (pamidronate or zoledronic acid) is the cornerstone for the management of multiple myeloma-(MM-) related bone disease. However, osteonecrosis of the jaw (ONJ) is a rare, but sometimes difficult to manage, adverse effect of bisphosphonates therapy. A retrospecti...
Saved in:
| Main Authors: | Pelagia I. Melea, Ioannis Melakopoulos, Efstathios Kastritis, Christina Tesseromatis, Vasileios Margaritis, Meletios A. Dimopoulos, Evangelos Terpos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | International Journal of Dentistry |
| Online Access: | http://dx.doi.org/10.1155/2014/427273 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Observation or treatment for smoldering multiple myeloma? A systematic review and meta-analysis of randomized controlled studies
by: Ioannis Ntanasis-Stathopoulos, et al.
Published: (2025-05-01) -
Bisphosphonate-Related Osteonecrosis of the Jaw Mimicking Bone Metastasis
by: Geetika Bhatt, et al.
Published: (2014-01-01) -
Assessment Results of Dental Students' Knowledge about Bisphosphonates and Bisphosphonate-Related Osteonecrosis of the Jaw
by: Greta Sereikaite, et al.
Published: (2023-12-01) -
Knowledge of Brazilian dentists about bisphosphonate-associated osteonecrosis of the jaw
by: Thainara Alexia Marinho de Souza, et al.
Published: (2024-04-01) -
Comprehensive Approach to the Treatment and Prevention of Bisphosphonate-Induced Osteonecrosis of the Jaw
by: Pilipov, I.A., et al.
Published: (2025-04-01)